secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0000950170-23-033021
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences stockholders elect directors, approve equity plan increase, ratify auditor
--------------------------------------------------------------------------------

- Quorum of 2,309,314 shares (>1/3 of 5,773,983 outstanding) present or proxy.
- Directors Jennifer Carver (1,281,109 for) and Curt LaBelle (1,280,290 for) elected to Class A.
- Approved amendment to 2021 Equity Incentive Plan: shares reserved increased from 68,288 to 648,678 (1,124,336 for).
- Ratified Baker Tilly US, LLP as auditor for fiscal year ending Dec 31, 2023 (1,981,630 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017023033021/0000950170-23-033021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017023033021/revb-20230714.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-033021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer